Generate the anatomy and physiology of the 11 human body system l
| System | Key Organs | Primary Functions |
|---|---|---|
| Integumentary | Skin, hair, nails, glands | Protection, thermoregulation, sensation, Vitamin D |
| Skeletal | 206 bones, cartilage, joints | Support, protection, movement, hematopoiesis, mineral storage |
| Muscular | Skeletal, cardiac, smooth muscle | Locomotion, posture, heat production, visceral movement |
| Nervous | Brain, spinal cord, nerves | Communication, integration, control, sensation |
| Endocrine | Pituitary, thyroid, adrenals, pancreas, gonads | Hormone-based regulation, metabolism, reproduction, growth |
| Cardiovascular | Heart, arteries, veins, capillaries | Pumps blood, distributes O₂/nutrients, removes CO₂/waste |
| Respiratory | Lungs, airways, respiratory muscles | Gas exchange (O₂ in, CO₂ out), acid-base balance |
| Digestive | Mouth → anus, liver, pancreas | Ingestion, digestion, absorption, elimination |
| Urinary | Kidneys, ureters, bladder, urethra | Filtration, excretion, fluid/electrolyte/acid-base balance |
| Reproductive | Gonads, ducts, accessory organs | Gamete production, fertilization, development |
| Lymphatic/Immune | Thymus, lymph nodes, spleen, lymphatics | Fluid return, immune surveillance, pathogen defense |
And its disease example
| Disease | Type | Key Features |
|---|---|---|
| Melanoma | Malignant | Uncontrolled growth of melanocytes; ABCDE criteria (Asymmetry, Border, Color, Diameter, Evolving); linked to UV exposure; can metastasize widely |
| Psoriasis | Autoimmune | T-cell mediated hyperproliferation of keratinocytes; thick, silvery plaques on extensor surfaces; Koebner phenomenon |
| Atopic Dermatitis (Eczema) | Inflammatory/Allergic | Defective filaggrin in stratum corneum → impaired barrier; intense pruritus, erythema, lichenification; strongly associated with asthma and allergic rhinitis |
| Basal Cell Carcinoma | Malignant | Most common skin cancer; arises from basal layer of epidermis; pearly, rolled edges with central ulceration; rarely metastasizes |
| Burns | Traumatic | Loss of barrier, fluid/electrolyte shifts (Parkland formula for resuscitation), infection risk; classified by depth (superficial, partial thickness, full thickness) |
| Cellulitis | Infectious | Bacterial (Staph/Strep) infection of dermis and subcutaneous tissue; erythema, warmth, swelling, pain; risk of sepsis if untreated |
| Disease | Type | Key Features |
|---|---|---|
| Osteoporosis | Metabolic | Decreased bone mineral density (BMD); imbalance between osteoclast resorption and osteoblast formation; T-score ≤ -2.5 on DEXA; risk of fragility fractures (hip, vertebral, wrist) - Goldman-Cecil Medicine |
| Osteoarthritis | Degenerative | Breakdown of articular cartilage (loss of proteoglycans, chondrocyte death); subchondral bone sclerosis, osteophytes, joint space narrowing; affects weight-bearing joints (knees, hips) |
| Rheumatoid Arthritis | Autoimmune | Synovitis driven by anti-CCP and RF antibodies; pannus formation erodes cartilage and bone; symmetric small joint involvement; systemic inflammation |
| Osteosarcoma | Malignant | Most common primary bone malignancy in adolescents; arises in metaphysis of long bones; "sunburst" pattern on X-ray; associated with Rb gene mutations |
| Paget's Disease of Bone | Metabolic | Excessive and disorganized bone remodeling; elevated ALP; can cause deafness, skull enlargement, pathological fractures; treated with bisphosphonates |
| Rickets/Osteomalacia | Nutritional | Vitamin D deficiency → impaired calcium/phosphate deposition in osteoid; soft bones; bowing of legs in children; Looser zones on X-ray in adults |
| Disease | Type | Key Features |
|---|---|---|
| Duchenne Muscular Dystrophy (DMD) | Genetic | X-linked recessive; dystrophin gene mutation → absent dystrophin protein → sarcolemmal fragility → progressive muscle necrosis; Gowers' sign; CK markedly elevated; cardiomyopathy |
| Myasthenia Gravis | Autoimmune | Antibodies against nicotinic ACh receptors at NMJ → impaired neuromuscular transmission; fatigable weakness (ptosis, diplopia, bulbar weakness); Tensilon (edrophonium) test positive |
| Rhabdomyolysis | Traumatic/Metabolic | Massive skeletal muscle breakdown → myoglobin release → acute kidney injury; elevated CK >10,000 U/L; dark (tea-colored) urine |
| Polymyositis/Dermatomyositis | Autoimmune/Inflammatory | CD8⁺ T-cell attack on muscle fibers (polymyositis); Gottron's papules, heliotrope rash (dermatomyositis); proximal muscle weakness; elevated CK and aldolase |
| Compartment Syndrome | Traumatic | Increased pressure within a fascial compartment → ischemia; 5 P's: Pain (with passive stretch), Pallor, Paresthesia, Paralysis, Pulselessness; surgical emergency |
| Disease | Type | Key Features |
|---|---|---|
| Ischemic Stroke | Vascular | Thromboembolic or lacunar occlusion of cerebral arteries → neuronal death within minutes (ischemic penumbra); FAST acronym; tPA within 4.5 hours; thrombectomy up to 24 hours |
| Alzheimer's Disease | Neurodegenerative | Amyloid-beta plaques and neurofibrillary tangles (tau protein); progressive episodic memory loss, aphasia, apraxia; medial temporal lobe (hippocampus) affected first |
| Multiple Sclerosis (MS) | Autoimmune | Demyelination of CNS white matter by autoreactive T-cells; relapsing-remitting most common; oligoclonal bands in CSF; MRI - periventricular plaques |
| Parkinson's Disease | Neurodegenerative | Loss of dopaminergic neurons in substantia nigra → dopamine depletion in striatum; TRAP: Tremor (resting, pill-rolling), Rigidity (cogwheel), Akinesia, Postural instability; Lewy bodies |
| Epilepsy | Neurological | Recurrent seizures from abnormal synchronized neuronal discharge; focal or generalized; EEG abnormalities; treated with antiepileptics targeting Na⁺/Ca²⁺ channels or GABA |
| Meningitis | Infectious | Bacterial (N. meningitidis, S. pneumoniae) or viral (enteroviruses) inflammation of meninges; classic triad: fever, neck stiffness, photophobia; CSF analysis is diagnostic |
| Guillain-Barré Syndrome | Autoimmune | Post-infectious ascending demyelinating polyneuropathy; areflexia, ascending weakness; cytoalbuminous dissociation in CSF (high protein, normal cells); IVIG or plasmapheresis |
| Disease | Type | Key Features |
|---|---|---|
| Type 1 Diabetes Mellitus | Autoimmune | Autoimmune destruction of beta cells (HLA-DR3/DR4 linked) → absolute insulin deficiency → hyperglycemia, DKA risk; requires lifelong insulin; onset typically in childhood/young adults - Guyton & Hall |
| Type 2 Diabetes Mellitus | Metabolic | Peripheral insulin resistance + progressive beta-cell failure; hyperglycemia, dyslipidemia, hypertension (metabolic syndrome); HbA1c used for monitoring; can lead to nephropathy, retinopathy, neuropathy, vasculopathy - Guyton & Hall |
| Hypothyroidism | Deficiency | Low T3/T4 → decreased BMR; weight gain, cold intolerance, bradycardia, constipation, myxedema; most common cause: Hashimoto's thyroiditis (autoimmune); treated with levothyroxine |
| Hyperthyroidism (Graves' Disease) | Autoimmune | TSH-receptor stimulating antibodies → excess T3/T4; weight loss, heat intolerance, tachycardia, exophthalmos, pretibial myxedema; treated with antithyroids, radioiodine, or thyroidectomy |
| Cushing's Syndrome | Hormonal excess | Excess glucocorticoids (most common cause: exogenous steroids; endogenous: ACTH-secreting pituitary adenoma = Cushing's disease); central obesity, moon face, buffalo hump, striae, hypertension, diabetes, osteoporosis |
| Addison's Disease | Deficiency | Primary adrenal insufficiency; cortisol and aldosterone deficiency; hypotension, hyponatremia, hyperkalemia, hyperpigmentation (elevated ACTH); can precipitate life-threatening adrenal crisis |
| Acromegaly | Hormonal excess | Excess GH in adults (usually pituitary adenoma) → excess IGF-1; coarsening of facial features, enlarged hands/feet, macroglossia, sleep apnea, diabetes, cardiomegaly |
| Disease | Type | Key Features |
|---|---|---|
| Acute Myocardial Infarction (MI) | Ischemic | Rupture of atherosclerotic plaque → coronary thrombosis → myocardial necrosis; STEMI vs NSTEMI (based on ECG and troponin); "time is muscle" - reperfusion via PCI or thrombolysis - Braunwald's Heart Disease |
| Heart Failure | Functional | Reduced cardiac output to meet metabolic demands; systolic (reduced EF) or diastolic (preserved EF) dysfunction; Framingham criteria; Starling law derangement; RAAS activation perpetuates fluid retention - Brenner and Rector's Kidney |
| Hypertension | Vascular | Sustained BP >130/80 mmHg; silent killer; damages target organs (heart, kidney, brain, eyes, vessels); essential (95%) vs secondary; treated with lifestyle + antihypertensives (ACEi, ARBs, CCBs, thiazides) |
| Atrial Fibrillation | Arrhythmia | Chaotic atrial electrical activity; irregularly irregular pulse; stroke risk (Virchow's triad in left atrial appendage); CHA₂DS₂-VASc score for anticoagulation; rate vs rhythm control |
| Infective Endocarditis | Infectious | Bacterial (Streptococcus, Staphylococcus) infection of cardiac valves; vegetation formation → valve destruction, emboli; Osler's nodes, Janeway lesions, Roth spots; Duke criteria for diagnosis |
| Deep Vein Thrombosis / PE | Thromboembolic | Virchow's triad (stasis, hypercoagulability, endothelial damage); DVT → pulmonary embolism; Wells score, D-dimer, CT pulmonary angiography; anticoagulation treatment |
| Disease | Type | Key Features |
|---|---|---|
| Asthma | Obstructive/Inflammatory | Reversible airway bronchoconstriction, inflammation, hyperresponsiveness; triggered by allergens, exercise, cold, infections; eosinophilic inflammation; β₂-agonists (acute relief), inhaled corticosteroids (maintenance) |
| COPD | Obstructive (irreversible) | Emphysema (alveolar wall destruction, loss of elastic recoil) + chronic bronchitis ("blue bloater" - excess mucus, cough ≥3 months/2 years); FEV₁/FVC <0.70; caused by smoking; managed with bronchodilators, pulmonary rehab |
| Pneumonia | Infectious | Alveolar consolidation by bacteria (S. pneumoniae most common), viruses, or fungi; lobar, broncho-, or interstitial patterns; productive cough, fever, crackles; CXR consolidation |
| Pulmonary Embolism (PE) | Vascular | DVT fragment lodges in pulmonary vasculature → V/Q mismatch, right heart strain; sudden dyspnea, pleuritic chest pain, hemoptysis; Wells score + CTPA for diagnosis |
| Idiopathic Pulmonary Fibrosis (IPF) | Restrictive/Fibrotic | Progressive fibrosis of alveolar walls → reduced compliance, reduced DLCO; "honeycomb" pattern on HRCT; UIP pattern on biopsy; no cure, nintedanib/pirfenidone slow progression |
| Lung Cancer | Malignant | Non-small cell (adenocarcinoma, squamous cell) vs small-cell (SCLC); strongly linked to smoking; para-neoplastic syndromes; EGFR/ALK mutations guide targeted therapy |
| Tuberculosis (TB) | Infectious | Mycobacterium tuberculosis; latent vs active; Ghon complex (primary); cavitary lesions (secondary reactivation); acid-fast bacilli on smear; RIPE therapy |
| Disease | Type | Key Features |
|---|---|---|
| Inflammatory Bowel Disease (IBD) | Autoimmune/Inflammatory | Two major forms: Crohn's disease (transmural inflammation, any GI segment, skip lesions, granulomas, cobblestoning) and Ulcerative colitis (mucosal inflammation, rectum to colon, continuous, pseudopolyps); complex polygenic disorders with peak incidence in 2nd-4th decade - Goldman-Cecil Medicine |
| Peptic Ulcer Disease (PUD) | Inflammatory | Mucosal erosion into submucosa/muscularis; H. pylori infection (70% of duodenal, 90% of gastric) + NSAIDs disrupt mucosal defense; epigastric pain, GI bleeding (hematemesis, melena) |
| Cirrhosis | Fibrotic/End-stage | Hepatocyte death → fibrosis → nodular regeneration; causes: alcohol, NAFLD, viral hepatitis (B, C); portal hypertension (varices, splenomegaly, ascites), hepatic encephalopathy, coagulopathy, jaundice |
| Colorectal Cancer | Malignant | Adenoma → carcinoma sequence (APC gene mutation); FAP (familial polyposis); Lynch syndrome (MSI); screening by colonoscopy; change in bowel habits, rectal bleeding |
| Acute Pancreatitis | Inflammatory | Premature activation of pancreatic enzymes → auto-digestion; causes: gallstones (most common), alcohol; epigastric pain radiating to back, elevated lipase/amylase; Ranson criteria for severity |
| Gastroesophageal Reflux Disease (GERD) | Functional/Inflammatory | Lower esophageal sphincter dysfunction → acid reflux; heartburn, regurgitation; Barrett's esophagus (columnar metaplasia) → adenocarcinoma risk; treated with PPIs |
| Disease | Type | Key Features |
|---|---|---|
| Chronic Kidney Disease (CKD) | Degenerative | Progressive irreversible loss of renal function; causes: hypertension, diabetes (nephrosclerosis), chronic glomerulonephritis, polycystic kidney disease; GFR <60 mL/min for >3 months = CKD; stages 1-5 (ESRD at stage 5) - Henry's Clinical Diagnosis |
| Acute Kidney Injury (AKI) | Functional | Sudden decline in GFR; prerenal (hypovolemia, shock), intrinsic (ATN, glomerulonephritis), postrenal (obstruction); KDIGO criteria; oliguria, rising creatinine, electrolyte disturbances |
| Nephrotic Syndrome | Glomerular | Massive proteinuria (>3.5 g/day) → hypoalbuminemia → edema, hyperlipidemia, lipiduria; causes: minimal change disease (children), focal segmental glomerulosclerosis, membranous nephropathy |
| Nephritic Syndrome | Glomerular | Hematuria (RBC casts), hypertension, oliguria, mild proteinuria; causes: post-streptococcal GN, IgA nephropathy (most common worldwide), lupus nephritis, Goodpasture's |
| Urinary Tract Infection (UTI) | Infectious | E. coli most common; cystitis (lower): dysuria, frequency, urgency; pyelonephritis (upper): flank pain, fever, costovertebral tenderness; urine culture guides antibiotic therapy |
| Renal Cell Carcinoma (RCC) | Malignant | Clear cell (most common, VHL gene); classic triad: hematuria, flank pain, palpable mass; paraneoplastic syndromes (erythrocytosis, hypercalcemia); treated with nephrectomy + targeted therapy (sunitinib) |
| Polycystic Kidney Disease (PKD) | Genetic | Autosomal dominant (PKD1/PKD2 mutations); progressive cyst enlargement → CKD; hypertension, hematuria; associated with berry aneurysms, mitral valve prolapse, liver cysts |
| Disease | Type | Key Features |
|---|---|---|
| Polycystic Ovary Syndrome (PCOS) | Endocrine/Reproductive | Androgen excess, oligoanovulation, polycystic ovaries; insulin resistance; irregular periods, hirsutism, acne, infertility; Rotterdam criteria (2 of 3 features); managed with OCPs, metformin, clomiphene |
| Endometriosis | Inflammatory | Ectopic endometrial tissue outside uterus (ovaries, pelvic peritoneum); cyclical pain, dysmenorrhea, dyspareunia, infertility; chocolate cysts (endometriomas); laparoscopy is gold standard for diagnosis |
| Benign Prostatic Hyperplasia (BPH) | Hyperplastic | DHT-driven stromal and glandular hyperplasia of transitional zone; lower urinary tract symptoms (LUTS): hesitancy, weak stream, nocturia; PSA may be elevated; α-blockers and 5α-reductase inhibitors |
| Prostate Cancer | Malignant | Most common male cancer (after skin); adenocarcinoma of peripheral zone; PSA screening; Gleason score; BRCA2 mutations increase risk; androgen deprivation therapy for advanced disease |
| Cervical Cancer | Malignant | HPV 16/18 infection → squamous cell carcinoma or adenocarcinoma; preventable with HPV vaccine; screened with Pap smear + HPV co-testing; radical hysterectomy or radiation/chemotherapy |
| Ectopic Pregnancy | Obstetric | Implantation outside uterus (usually fallopian tube ampulla); rupture → hemorrhage, shock; hCG rises abnormally slowly; transvaginal ultrasound diagnostic; methotrexate (early) or surgery |
| Testicular Cancer | Malignant | Most common solid cancer in young men (15-35 yrs); germ cell tumors (seminoma, non-seminoma); painless testicular mass; elevated AFP, β-hCG, LDH; highly curable with chemotherapy (BEP regimen) |
| Disease | Type | Key Features |
|---|---|---|
| Hodgkin Lymphoma | Malignant | Reed-Sternberg cells (B-cell origin, CD15⁺/CD30⁺); bimodal age distribution; painless lymphadenopathy, B symptoms (fever, night sweats, weight loss); highly curable with ABVD chemotherapy |
| Non-Hodgkin Lymphoma (NHL) | Malignant | Heterogeneous group; B-cell (diffuse large B-cell, follicular, Burkitt's) or T-cell; Burkitt's - c-Myc translocation t(8;14); associated with HIV, EBV, immunosuppression - Harrison's Principles |
| Leukemia | Malignant | Malignant proliferation of hematopoietic cells; ALL (childhood, B or T-cell), AML (adults), CLL (B-cell, elderly - most common adult leukemia), CML (BCR-ABL t(9;22) Philadelphia chromosome → imatinib) - Harrison's Principles |
| HIV/AIDS | Infectious/Immune | HIV destroys CD4⁺ T-helper cells → progressive immunodeficiency; AIDS: CD4 <200/µL or AIDS-defining illness; opportunistic infections (PCP, CMV, toxoplasmosis, Cryptococcus); ART (antiretroviral therapy) |
| Systemic Lupus Erythematosus (SLE) | Autoimmune | Multi-system autoimmune disease; anti-dsDNA and anti-Smith antibodies; malar rash, photosensitivity, oral ulcers, serositis, glomerulonephritis, cytopenias; SLICC criteria |
| Lymphedema | Lymphatic obstruction | Impaired lymph drainage → protein-rich interstitial fluid accumulation; primary (Milroy's disease) or secondary (post-mastectomy, filariasis); non-pitting edema; irreversible fibrosis if untreated |
| Anaphylaxis | Immune/Allergic | IgE-mediated mast cell and basophil degranulation → massive histamine, leukotrienes, prostaglandins release; urticaria, angioedema, bronchospasm, hypotension; epinephrine IM is first-line treatment |
| Common Variable Immunodeficiency (CVID) | Primary Immunodeficiency | Low immunoglobulins, poor vaccine responses; recurrent sinopulmonary infections; increased risk of autoimmunity and lymphoma; treated with IVIG replacement |
| Body System | Key Diseases (Examples) | Core Mechanism |
|---|---|---|
| Integumentary | Melanoma, Psoriasis, Eczema, Cellulitis | Barrier disruption, aberrant inflammation, malignant transformation |
| Skeletal | Osteoporosis, Osteoarthritis, RA, Osteosarcoma | Remodeling imbalance, cartilage degeneration, autoimmunity, malignancy |
| Muscular | DMD, Myasthenia Gravis, Rhabdomyolysis | Structural protein defect, NMJ dysfunction, muscle breakdown |
| Nervous | Stroke, Alzheimer's, MS, Parkinson's, Epilepsy | Ischemia, neurodegeneration, demyelination, dopamine loss, dysrhythmia |
| Endocrine | DM Type 1 & 2, Hypothyroidism, Cushing's, Addison's | Hormone deficiency or excess, receptor resistance, gland destruction |
| Cardiovascular | MI, Heart Failure, Hypertension, AF | Atherosclerosis, pump failure, increased vascular resistance, arrhythmia |
| Respiratory | Asthma, COPD, Pneumonia, IPF, Lung Cancer | Airway obstruction, inflammation, fibrosis, infection, malignancy |
| Digestive | IBD, PUD, Cirrhosis, Colorectal Cancer, Pancreatitis | Mucosal damage, autoimmunity, fibrosis, malignant transformation |
| Urinary | CKD, AKI, Nephrotic Syndrome, UTI, PKD | Nephron loss, filtration failure, glomerular damage, obstruction, infection |
| Reproductive | PCOS, Endometriosis, Prostate/Cervical Cancer, Ectopic | Hormonal imbalance, ectopic tissue, HPV/oncogene-driven malignancy |
| Lymphatic/Immune | HIV/AIDS, SLE, Leukemia, Lymphoma, Anaphylaxis | Immunodeficiency, autoimmunity, malignant lymphoproliferation, dysregulated IgE |
Difference between in dm 1 and dm 2 with explanation lije a story And body blood flow of oxygenated blood and deoxygenated blood exchange explain
"In type 1 diabetes, a complex interplay of genetic, environmental, and autoimmune factors selectively targets insulin-producing pancreatic islet β cells and ultimately destroys them... β-cell destruction is largely mediated by CD8+ and CD4+ T cells, macrophages - causing apoptosis or cellular destruction." - Goldman-Cecil Medicine
| DM Type 1 Quick Facts | |
|---|---|
| Who | Children, teenagers, young adults (but can occur at any age) |
| What happened | Beta cells completely destroyed by autoimmunity |
| Insulin level | Zero (absolute deficiency) |
| Antibodies | Anti-GAD65, anti-IA-2, anti-ZnT8, anti-insulin |
| Genes | HLA DR3-DQ2 / DR4-DQ8 on chromosome 6 (~50% of risk) |
| Onset | Sudden, dramatic - often presents in DKA |
| Body type | Usually thin/normal weight |
| Treatment | Insulin - always, no exceptions |
"Type 2 diabetes: a combination of insulin resistance and defective insulin secretion." - Henry's Clinical Diagnosis
| DM Type 2 Quick Facts | |
|---|---|
| Who | Middle-aged and older adults; increasingly younger due to obesity |
| What happened | Insulin resistance + gradual beta-cell exhaustion |
| Insulin level | Normal or HIGH early on; low later as beta cells fail |
| Antibodies | Usually none |
| Risk factors | Obesity (especially visceral), inactivity, family history, ethnicity |
| Onset | Slow, silent - often found incidentally on routine testing |
| Body type | Usually overweight/obese |
| Treatment | Lifestyle, metformin, GLP-1 agonists, SGLT2 inhibitors, eventually insulin |
| Feature | Type 1 DM | Type 2 DM |
|---|---|---|
| The story | Key factory destroyed | Locks became rusty |
| Core defect | Absolute insulin deficiency | Insulin resistance + relative insulin deficiency |
| Cause | Autoimmune (T-cell mediated) | Metabolic/lifestyle + genetic |
| Age of onset | Usually <30 years | Usually >40 years (but rising in younger people) |
| Body weight | Usually normal/thin | Usually overweight/obese |
| Speed of onset | Rapid (days to weeks) | Slow (years to decades) |
| DKA | Common, can be first presentation | Rare (possible in severe illness - "ketosis-prone T2D") |
| C-peptide | Very low/undetectable | Normal or elevated early; reduced later |
| Autoantibodies | Positive (GAD65, IA-2, ZnT8) | Negative |
| HLA association | DR3-DQ2, DR4-DQ8 | Not HLA-linked; TCF7L2, KCNJ11, PPARG genes |
| Twin concordance | 30-40% (identical twins) | ~70-90% (identical twins) |
| Insulin needed? | Always, from diagnosis | Only after beta-cell failure; many manage without |
| Reversible? | No - beta cells permanently gone | Partially - early T2D can remit with weight loss |
| Complications | Both share: retinopathy, nephropathy, neuropathy, cardiovascular disease |

Body tissues
↓ (used up O₂, full of CO₂)
Superior Vena Cava + Inferior Vena Cava
↓
Right Atrium → [Tricuspid Valve] → Right Ventricle
↓ [Pulmonic Valve]
Pulmonary Trunk → Right + Left Pulmonary ARTERIES
↓ (the ONLY arteries carrying deoxygenated blood!)
Pulmonary Capillaries surrounding Alveoli
↓ GAS EXCHANGE HAPPENS HERE:
O₂ diffuses IN (alveolar PO₂ ~100 mmHg → blood ~40 mmHg)
CO₂ diffuses OUT (blood PCO₂ ~45 mmHg → alveoli ~40 mmHg)
↓ (now fresh, oxygenated, bright red blood)
Pulmonary VEINS (the ONLY veins carrying oxygenated blood!)
↓
Left Atrium
"Deoxygenated blood from the systemic circulation flows from the right atrium into the right ventricle and from there into the pulmonary circulation... the blood is enriched with oxygen and carbon dioxide is released into the airways. The oxygenated blood leaves the lungs by the pulmonary veins and flows to the left atrium." - Color Atlas of Human Anatomy Vol. 2
Left Atrium → [Mitral Valve] → Left Ventricle
↓ [Aortic Valve]
AORTA (pumped at 120 mmHg systolic - high pressure)
↓ branches into organ-specific arteries
├── Cerebral arteries → Brain (15% of cardiac output)
├── Coronary arteries → Heart muscle (5%)
├── Renal arteries → Kidneys (25%)
├── Mesenteric/celiac arteries → GI tract (25%)
├── Skeletal muscle arteries → Muscles (25% at rest, up to 80% during exercise)
└── Cutaneous arteries → Skin (5%)
↓ (at each organ: capillaries)
GAS EXCHANGE:
O₂ leaves blood → enters cells
CO₂ leaves cells → enters blood
Nutrients (glucose, amino acids) delivered
Waste products (CO₂, urea, lactic acid) collected
↓ (now deoxygenated, dark red blood)
├── Veins from legs/abdomen → Inferior Vena Cava
└── Veins from head/arms → Superior Vena Cava
↓
Right Atrium (cycle restarts)
"Oxygenated blood from the lung flows from the left atrium of the heart into the left ventricle. From there it is pumped through the aorta into the systemic circulation, which consists of numerous separate circuits supplying individual organs... At the capillary plexus, exchange of gases and metabolic products occurs." - Color Atlas of Human Anatomy Vol. 2
GI capillaries (nutrient-rich after eating)
↓
Portal Vein
↓
Liver sinusoids (hepatocytes process glucose, amino acids, toxins)
↓
Hepatic Veins
↓
Inferior Vena Cava → Right Atrium
| Gas | Direction | Driving Force |
|---|---|---|
| O₂ | Alveolus → Blood | PO₂ alveolus ~100 mmHg vs. blood ~40 mmHg |
| CO₂ | Blood → Alveolus | PCO₂ blood ~45 mmHg vs. alveolus ~40 mmHg |
| Gas | Direction | Driving Force |
|---|---|---|
| O₂ | Blood → Cell | PO₂ arterial blood ~95 mmHg vs. tissue ~40 mmHg |
| CO₂ | Cell → Blood | PCO₂ tissue ~46 mmHg vs. arterial blood ~40 mmHg |